Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.486NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.486NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.603NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.603NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.603NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.70NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.70NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
B.1.1.70NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.606NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.606NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.606NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.601NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.601NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.601NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.186NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.186NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.186NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.324NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.324NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.324NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.525NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.525NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.525NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.480NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.480NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.480NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.214NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.214NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.214NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.304NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.304NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.304NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.214.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.214.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.214.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.577NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.577NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.577NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.639NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.639NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.639NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.2.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.2.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AZ.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AZ.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used